Abstract: The present invention concerns diagnosing and/or prognosticating cancer in an individual and/or determining response to a Hsp90-interacting therapy in an individual. In particular, the methods and compositions of the therapy relate to levels of Hsp90-? in plasma. Additional methods concern determining levels of Hsp90-associated molecules.
Type:
Application
Filed:
November 26, 2007
Publication date:
May 27, 2010
Applicant:
University of Maryland Balitmore
Inventors:
Edward A. Sausville, Angelika M. Burger